搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 3 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
North Korea fires suspected short-range missiles into the sea in its latest weapons test
Bastillepost· 3 日前North Korea on Monday test-fired suspected short-range ballistic missiles into the sea, the ...
Goldman Sachs upbeat on A shares
China Daily· 2 日前Goldman Sachs, a global investment banking, securities and investment management firm, sees double-digit growth potential ...
Chinese economy achieves good start in Q1: official
Bastillepost· 6 日前The Chinese economy got off to a good start in 2024 as several indicators showed positive signs ...